D
Avicanna Inc. AVCN.TO
TSX
Recommendation
Sell
Prev Close
$0.42
Volume
--
Avg Vol (90D)
80,999
Market Cap
$28.08M
Dividend & Yield
--
52-Week Range
$0.23 - $0.60
P/E (TTM)
--
EPS (TTM)
-$0.076
My Lists My Alerts
Report
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Weak
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
$12.44M
EBITDA (TTM)
-$5.82M
EBIT (TTM)
-$6.20M
Net Income (TTM)
-$6.47M
Balance Sheet
Total Assets (Q)
$16.64M
Total Debt (Q)
$1.37M
Total Liabilities (Q)
$10.60M
Book Value Per Share (Q)
-$0.0009
Cash Flow
Cash from Operations (TTM)
-$1.02M
Cash from Investing (TTM)
-$2.27M
Cash from Financing (TTM)
$2.63M
Net Change in Cash (TTM)
-$525.80K
Filings
Filing Date
Tuesday, April 2, 2024
Period Date
Sunday, December 31, 2023
Next Filing
Week of May 13 and 17 (est)
Price History
Loading...
Beta
0.34
7-Day Total Return
12.82%
30-Day Total Return
-8.33%
60-Day Total Return
39.68%
90-Day Total Return
-10.20%
Year to Date Total Return
25.71%
1-Year Total Return
12.82%
2-Year Total Return
51.72%
3-Year Total Return
-57.69%
5-Year Total Return
--
52-week Low
Aug 10, 2023 - $0.23
52-week High
Mar 18, 2024 - $0.60
Valuation
Market Cap
$28.08M - Nano Cap
Enterprise Value
$34.90M
Price/Sales (TTM)
3.20
Price/Book (Q)
-466.67
Dividends and Shares
Shares Outstanding
94.91M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.avicanna.com
Phone Number
Address
480 University Avenue
Toronto, ON M5G 1V2
Country
Canada
Year Founded
2016
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research and development of evidence-based products for consumer medical and pharmaceutical segments worldwide. The... more
Weiss Ratings